Document Detail


Agoraphobia: newer treatment approaches.
MedLine Citation:
PMID:  702127     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Agoraphobia is the commonest and most severe form of phobic disorder. Techniques presently available for its treatment fall into the broad categories of behavior therapy, pharmacotherapy, and psychotherapy. Of the behavioral approaches in current use flooding is probably most effective. Group exposure methods are valuable and have the advantage of conserving therapist time. Pharmacological agents of demonstrated value include monoamine oxidase inhibitors (phenelzine) and tricyclic antidepressants (imipramine). These drugs are capable of preventing the spontaneous panic attacks observed in agoraphobic patients. Psychotherapy, once the mainstay of treatment, has largely become an adjunctive procedure.
Authors:
R G Rohs; R Noyes
Related Documents :
11459337 - Psychotropic drug use in italy, 1984-99: the impact of a change in reimbursement status.
3983467 - Antidepressant drugs suppress growth of the human pathogenic protozoan giardia lamblia.
8153697 - A practical approach to the management of depression.
19434367 - Pharmacogenetics of anxiolytic drugs.
24799417 - Nano regulation of cisplatin chemotherapeutic behaviors by biomineralization controls.
12911677 - Prescription drug samples--does this marketing strategy counteract policies for quality...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of nervous and mental disease     Volume:  166     ISSN:  0022-3018     ISO Abbreviation:  J. Nerv. Ment. Dis.     Publication Date:  1978 Oct 
Date Detail:
Created Date:  1978-12-27     Completed Date:  1978-12-27     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0375402     Medline TA:  J Nerv Ment Dis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  701-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Agoraphobia / psychology,  therapy*
Behavior Therapy
Follow-Up Studies
Humans
Monoamine Oxidase Inhibitors / therapeutic use
Panic / drug effects
Phobic Disorders / therapy*
Psychotherapy
Chemical
Reg. No./Substance:
0/Monoamine Oxidase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Successive visual discrimination of forms in 10-month-old infants.
Next Document:  A multivariate analysis and modification of a preattentive, perceptual dysfunction in schizophrenia.